Accelerated approval was based on promising results from the ongoing Phase III BREAKWATER trial. The FDA has granted accelerated approval to Pfizer’s Braftovi (encorafenib) in combination with ...

High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS ...

In this part of his Pharmaceutical Executive video interview, Peter Ax, CEO of UpScriptHealth, explores the key factors driving the increasing number of partnerships between telehealth and ...

High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS ...

In the third part of this roundtable discussion, experts discuss the issues with data that AI must overcome. Pharmaceutical Executive recently brought together a group of experts to discuss the ...

High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS ...

High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS ...

Approval was based on positive results from the Phase III balance study, where Tryngolza demonstrated a notable placebo-adjusted triglyceride reduction at 12 months. The FDA has approved Ionis ...

Talking about ethics isn’t exactly exciting. Leaders don’t usually jump at the chance to emphasize following rules or exceeding standards—it’s much more appealing to focus on growth than on problems.

High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS ...

How alternative direct-to-consumer models are changing the landscape for patient access.

High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS ...